| No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
| 1 |
chr12:48328400-48337800 |
Enhancers |
Fetal Heart |
heart
|
| 2 |
chr12:48332600-48339600 |
Weak transcription |
NHDF-Ad |
bronchial
|
| 3 |
chr12:48332800-48337400 |
Weak transcription |
HMEC |
breast
|
| 4 |
chr12:48332800-48337400 |
Weak transcription |
NHEK |
skin
|
| 5 |
chr12:48332800-48340200 |
Weak transcription |
Right Atrium |
heart
|
| 6 |
chr12:48333000-48339200 |
Weak transcription |
HSMM |
muscle
|
| 7 |
chr12:48333600-48336200 |
Weak transcription |
Small Intestine |
intestine
|
| 8 |
chr12:48333800-48337000 |
Weak transcription |
Hela-S3 |
cervix
|
| 9 |
chr12:48334000-48336800 |
Bivalent Enhancer |
Primary Natural Killer cells fromperipheralblood |
blood
|
| 10 |
chr12:48334200-48336600 |
Weak transcription |
Rectal Mucosa Donor 31 |
rectum
|
| 11 |
chr12:48334400-48336400 |
Weak transcription |
Colonic Mucosa |
Colon
|
| 12 |
chr12:48335000-48336400 |
Enhancers |
Duodenum Mucosa |
Duodenum
|
| 13 |
chr12:48335000-48337000 |
Bivalent Enhancer |
Fetal Stomach |
stomach
|
| 14 |
chr12:48335200-48336000 |
Bivalent Enhancer |
H1 Cell Line |
embryonic stem cell
|
| 15 |
chr12:48335200-48336000 |
Bivalent Enhancer |
HUES6 Cell Line |
embryonic stem cell
|
| 16 |
chr12:48335200-48336200 |
Enhancers |
HSMMtube |
muscle
|
| 17 |
chr12:48335200-48336600 |
Enhancers |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
| 18 |
chr12:48335200-48337000 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
| 19 |
chr12:48335200-48337000 |
Bivalent Enhancer |
Fetal Adrenal Gland |
Adrenal Gland
|
| 20 |
chr12:48335200-48337600 |
Bivalent Enhancer |
Fetal Muscle Trunk |
muscle
|
| 21 |
chr12:48335400-48336200 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
| 22 |
chr12:48335400-48336200 |
Bivalent Enhancer |
Fetal Thymus |
thymus
|
| 23 |
chr12:48335600-48336200 |
Bivalent Enhancer |
HUES48 Cell Line |
embryonic stem cell
|
| 24 |
chr12:48335600-48337000 |
Enhancers |
Placenta |
Placenta
|
| 25 |
chr12:48335800-48336000 |
Flanking Bivalent TSS/Enh |
ES-WA7 Cell Line |
embryonic stem cell
|
| 26 |
chr12:48335800-48336000 |
Flanking Bivalent TSS/Enh |
iPS-18 Cell Line |
embryonic stem cell
|
| 27 |
chr12:48335800-48336000 |
Flanking Bivalent TSS/Enh |
ES-UCSF4 Cell Line |
embryonic stem cell
|
| 28 |
chr12:48335800-48336000 |
Bivalent/Poised TSS |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
| 29 |
chr12:48335800-48336000 |
Bivalent Enhancer |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
| 30 |
chr12:48335800-48336000 |
Enhancers |
Fetal Intestine Small |
intestine
|
| 31 |
chr12:48335800-48336000 |
Enhancers |
Placenta Amnion |
Placenta Amnion
|
| 32 |
chr12:48335800-48336000 |
Bivalent Enhancer |
Skeletal Muscle Male |
skeletal muscle
|
| 33 |
chr12:48335800-48336200 |
Bivalent/Poised TSS |
HUES64 Cell Line |
embryonic stem cell
|
| 34 |
chr12:48335800-48336200 |
Flanking Active TSS |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
| 35 |
chr12:48335800-48336200 |
Bivalent Enhancer |
Primary B cells from peripheral blood |
blood
|
| 36 |
chr12:48335800-48336200 |
Bivalent Enhancer |
Adipose Nuclei |
Adipose
|
| 37 |
chr12:48335800-48336200 |
Bivalent Enhancer |
Fetal Intestine Large |
intestine
|
| 38 |
chr12:48335800-48336600 |
Bivalent Enhancer |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
| 39 |
chr12:48335800-48336600 |
Bivalent/Poised TSS |
iPS-15b Cell Line |
embryonic stem cell
|
| 40 |
chr12:48335800-48336600 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
| 41 |
chr12:48335800-48336600 |
Bivalent Enhancer |
Fetal Muscle Leg |
muscle
|
| 42 |
chr12:48335800-48336600 |
Enhancers |
Right Ventricle |
heart
|
| 43 |
chr12:48335800-48337000 |
Bivalent Enhancer |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
| 44 |
chr12:48335800-48338200 |
Enhancers |
Spleen |
Spleen
|
| 45 |
chr12:48335800-48346000 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
